GlaxoSmithKline Pharmaceuticals Limited informed that Mr. Mark Dawson, Non- Executive Director of the Company have tendered his resignation with effect from closing hours of June 30, 2022. The Company places on record its appreciation for the guidance and support provided by Mr. Mark Dawson during his tenure.